Phibro Animal Health Corporation
PAHC
$39.45
$0.380.97%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 1,897.68% | 141.54% | 30.53% | -16.05% | -92.59% |
Total Depreciation and Amortization | 27.18% | 20.13% | 12.43% | 5.75% | 6.71% |
Total Amortization of Deferred Charges | 38.77% | 28.23% | 18.98% | 12.55% | 13.47% |
Total Other Non-Cash Items | -60.92% | -120.69% | -61.60% | 28.38% | 215.07% |
Change in Net Operating Assets | -165.11% | -28.80% | -124.12% | 369.98% | 180.50% |
Cash from Operations | -8.53% | 9.92% | -25.21% | 108.96% | 558.11% |
Capital Expenditure | 7.14% | 2.14% | -7.99% | -20.09% | 20.38% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -8,630.32% | -8,793.30% | -8,642.66% | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 1,083.51% | 659.86% | 224.93% | 129.24% | 83.47% |
Cash from Investing | -499.01% | -489.01% | -207.44% | 51.15% | 34.89% |
Total Debt Issued | 317.98% | 410.88% | 472.94% | 158.79% | -14.37% |
Total Debt Repaid | -250.31% | -323.63% | -350.63% | -180.68% | 4.41% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -0.04% | -0.02% | 0.01% | 0.00% | 0.00% |
Other Financing Activities | -- | -269.50% | -150.27% | -236.93% | 100.00% |
Cash from Financing | 3,160.49% | 1,555.55% | 1,404.23% | -3,496.62% | -125.08% |
Foreign Exchange rate Adjustments | 65.33% | -42.05% | -92.77% | -349.19% | -537.67% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -108.78% | -22.01% | 196.20% | 126.21% | 188.97% |